The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
Apple is moving into health care with the launch of its ResearchKit. It will essentially turn a device from the tech giant into a diagnostic tool for a range of diseases including Parkinson's, asthma and diabetes among others.
Kathryn Schmitz is a professor of epidemiology at the University of Pennsylvania and helped create "Share the Journey," an app that focuses on breast cancer patients and works with ResearchKit. She called it a "game changer" in the way researchers collect large amounts of data from patients across the country.
"This changes our ability to recruit on thousands and tens of thousands, where in the past we could only recruit on tens and hundreds," she told CNBC's "Squawk on the Street " on Tuesday.
The app will track symptoms like fatigue, cognitive difficulties, sleep disturbance and mood changes. More importantly, Schmitz explained, is the platform itself which allows researches to build whatever they want in order to track whatever symptoms they need.
"That is the promise and that's what is really exciting. We have chosen a few things that are common complaints among breast cancer survivors for us to build the platform to show that it works and to show other researchers the power of this platform."
She added that functions that can monitor blood pressure, blood alcohol levels, or stress might not be "very far away" but will depend on FDA approval which could be a long process in and of itself.
Andy Hargreaves, Pacific Crest Securities senior research analyst, told CNBC's "Squawk on the Street" that there are lots of data collection services and "some are arguably better for fitness and health purposes."
"I think it's still unclear whether or not we want the full robustness of an Apple Watch or whether we want really purpose-built data collection like you'd get from a Fitbit or something that's smaller and lighter and has a longer battery life."